Long-term Survival of Glioblastoma Multiforme Patients Treated with Tumor-treating FieldsGlioblastoma multiforme(GBM),the most common and malignant primary intracranial tumor,has a median survival of only 10 to 14 months with only 3 to 5%of patients surviving more than three years.Recurrence(RGBM) ...
However, long-term survival in ES-SCLC, even with the addition of immunotherapy, continues to be rare. We present the case of a middle-aged male patient diagnosed with ES-SCLC who was treated with four cycles of induction chemotherapy (carboplatin and etoposide) and atezolizumab, starting ...
PATH-01. Identification of Prognastic Variables Based on Molecular Profiling of Long-Term and Short-Term Surviving Gglioblastoma Patients Despite extensive treatment, overall survival (OS) for glioblastoma (GBM) remains poor. A small proportion of patients present long survival over 3 years, ... SR...
Long-term survival in patients with glioblastoma multiforme. Few patients with glioblastoma multiforme survive more than 5 years. To identify the factors associated with long-term survival, patients with primary supr... KL Chandler,M Prados,M Malec,... - 《Neurosurgery》 被引量: 0发表: 1993年...
We agree with the authors that such long-term survival is possible, particularly in children; however, it is extremely rare. The senior author has an experience of a patient who was operated in 1975 at the age of 7years, with a biopsy-proven glioblastoma multiforme (GBM), who was well ...
Long term survival enhanced by cordectomy in a patient with a spinal glioblastomamultiforme and paraplegia. Case report. J Neurosurg Spine. 2007;7(6):656-659.Marchan EM, Sekula RF Jr, Jannetta PJ, Quigley MR: Long-term survival enhanced by cordectomy in a patient with a spinal glioblastoma...
An international Phase III study led by researchers at UCLA and at Northwest Biotherapeutics, Inc. has found that a personalized glioblastoma vaccine may increase long-term survival in some patients. Nearly 30 percent of patients in the current trial have now survived at...
Our study showed that both MIB-1 and topoisomerase IIα could help predict long-term survival of patients with glioblastomas. Multivariate analyses revealed that MIB-1 was a better prognostic marker than topoisomerase IIα. 展开 关键词: Glioblastoma MIB-1 Ki-67 DNA topoisomerase IIα ...
Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters PurposeSince the introduction of ipilimumab (IPI) for the treatment of patients with metastatic malignant melanoma, we have observed remarkable responses a......
CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival. J Clin Neurosci. 2010;17(11):1381 -1385.Yang, I.; Tihan, T.; Han, S.J.; Wrensch, M.R.; Wiencke, J.; Sughrue, M.E.; Parsa, A.T. CD8+ T-cell infiltrate in newly diagnosed ...